1
|
LA LADN, Hernández-Pereira CE, Castillo-Castañeda AC, Patiño LH, Castañeda S, Herrera G, Mogollón E, Muñoz M, Duran A, Loyo D, Pacheco M, Arena L, Isquiel G, Yepez L, Colmenarez B, Caviedes M, Mendez Y, Herrera S, Ramírez JD, Paniz-Mondolfi AE. Diversity and geographical distribution of Leishmania species and the emergence of Leishmania (Leishmania) infantum and L. (Viannia) panamensis in Central-Western Venezuela. Acta Trop 2023; 242:106901. [PMID: 36940857 DOI: 10.1016/j.actatropica.2023.106901] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Revised: 03/13/2023] [Accepted: 03/16/2023] [Indexed: 03/23/2023]
Abstract
Transmission of cutaneous leishmaniasis in Venezuela reveals diverse and changing epidemiological landscapes, as well as a spectrum of clinical phenotypes presumed to be linked to a variety of Leishmania species. Central-western Venezuela constitutes one of the highest endemic epicenters in the country, yet updated molecular epidemiological information is still lacking. Therefore, in this study we aimed to characterize the landscape of circulating Leishmania species across central-western Venezuela through the last two decades, performed comparisons of haplotype and nucleotide diversity, and built a geospatial map of parasite species distribution. A total of 120 clinical samples were collected from patients across the cutaneous disease spectrum, retrieving parasitic DNA, and further characterizing by PCR and sequencing of the HSP70 gene fragment. This data was later collated with further genetic, geospatial and epidemiological analyses. A peculiar pattern of species occurrence including Leishmania (Leishmania) amazonensis (77.63% N=59), Leishmania (Leishmania) infantum (14.47% N=11), Leishmania (Viannia) panamensis (5.26% N=4) and Leishmania (Viannia) braziliensis (2.63% N=2) was revealed, also highlighting a very low genetic diversity amongst all analyzed sequences. Geographical distribution showed that most cases are widely distributed across the greater urban-sub urban area of the Irribaren municipality. L.(L.) amazonensis appears to be widely dispersed throughout Lara state. Statistical analyses failed to reveal significance for any comparisons, leading to conclude a lack of association between the infective Leishmania species and clinical phenotypes. To the best of our knowledge, this is an unprecedented study which addresses comprehensively the geographical distribution of Leishmania species in central-western Venezuela throughout the last two decades, and the first to incriminate L. (L.) infantum as an etiologic agent of cutaneous leishmaniasis in this region. Our findings support that Leishmania endemism in central-western Venezuela is caused mainly by L.(L.) amazonensis. Future studies are needed to unveil additional details on the ecological intricacies and transmission aspects of leishmaniasis (i.e. sampling phlebotomines and mammals) and to adopt adequate public health prevention and control strategies and mitigate disease impact in this endemic region.
Collapse
Affiliation(s)
- Lourdes A Delgado-Noguera LA
- Instituto de Investigaciones Biomédicas IDB/Emerging Pathogens Network-Incubadora Venezolana de la Ciencia, Cabudare, 3023, Venezuela; Escuela de Medicina "Dr Pablo Acosta Ortiz". Universidad Centroccidental Lisandro Alvarado (UCLA), Barquisimeto, Lara, Venezuela
| | - Carlos E Hernández-Pereira
- Instituto de Investigaciones Biomédicas IDB/Emerging Pathogens Network-Incubadora Venezolana de la Ciencia, Cabudare, 3023, Venezuela
| | - Adriana C Castillo-Castañeda
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
| | - Luz Helena Patiño
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia; Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Sergio Castañeda
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
| | - Giovanny Herrera
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
| | - Euler Mogollón
- Instituto de Investigaciones Biomédicas IDB/Emerging Pathogens Network-Incubadora Venezolana de la Ciencia, Cabudare, 3023, Venezuela; Escuela de Medicina "Dr Pablo Acosta Ortiz". Universidad Centroccidental Lisandro Alvarado (UCLA), Barquisimeto, Lara, Venezuela
| | - Marina Muñoz
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
| | - Alexander Duran
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Doris Loyo
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Mirna Pacheco
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Luzmir Arena
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Glenis Isquiel
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Lisbeth Yepez
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Beatriz Colmenarez
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Mayeli Caviedes
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Yamilet Mendez
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Sandry Herrera
- Servicio de Dermatología Sanitaria del Estado Lara, Barquisimeto, Venezuela
| | - Juan David Ramírez
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
| | - Alberto E Paniz-Mondolfi
- Instituto de Investigaciones Biomédicas IDB/Emerging Pathogens Network-Incubadora Venezolana de la Ciencia, Cabudare, 3023, Venezuela; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
| |
Collapse
|
2
|
Canine Leishmaniasis in an Endemic Area for Human Leishmaniasis in Nicaragua. J Trop Med 2022; 2022:5774296. [PMID: 36072825 PMCID: PMC9444458 DOI: 10.1155/2022/5774296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 07/20/2022] [Accepted: 08/17/2022] [Indexed: 12/02/2022] Open
Abstract
In this study, the frequency of canines infected with Leishmania spp. in an area endemic to leishmaniasis in humans was determined. A descriptive pilot study was conducted between the months of October and December 2020 on dogs from Rota, a community in the municipality of León, which included 45 specimens from the peridomestic area. Different variables from each specimen were monitored, such as age, sex, breed, body condition, and clinical characteristics, as well as information on the owners and cases of human leishmaniasis presented in less than 5 years. Blood samples were collected from the cephalic vein and peripheral blood was separated. A complete blood count (CBC) was performed using venous blood samples with ethylene diamine tetraacetic acid (EDTA), as well as a conventional PCR was applied for the detection of Leishmania spp. Amastigotes were found in 22% of venous or peripheral blood samples, whereas a high prevalence of 28.89% (95% CI: 14.53–43.24) was found by PCR. Only 1/12 of positive dogs in PCR presented dry exfoliative dermatitis, therefore, there was no significant difference (p ≥ 0.05), the age and sex of the dogs were also not factors associated with infection (p ≥ 0.05). This study reports for the first time the molecular detection of Leishmania in dogs in an endemic area of leishmaniasis in humans in Nicaragua. The high frequency of dogs infected with Leishmania suggests that they play an important role in the transmission cycle of human leishmaniasis.
Collapse
|
3
|
Hernández-Bojorge SE, Blass-Alfaro GG, Rickloff MA, Gómez-Guerrero MJ, Izurieta R. Epidemiology of cutaneous and mucocutaneous leishmaniasis in Nicaragua. Parasite Epidemiol Control 2020; 11:e00192. [PMID: 33313430 PMCID: PMC7721648 DOI: 10.1016/j.parepi.2020.e00192] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Revised: 11/19/2020] [Accepted: 11/22/2020] [Indexed: 11/28/2022] Open
Abstract
Leishmaniasis is a major neglected tropical disease which contributes a huge economic burden on already meager economic resources. The World Health Organization (WHO) has estimated an annual incidence of 700,000--1,000,000 patients and about 20,000–30,000 deaths per year. Approximately 66,941 patients of cutaneous leishmaniasis are reported annually in the Americas. In recent years, Nicaragua has presented alarmingly high numbers of patients and elevated incidence rates. Unfortunately, there are no detailed spatial descriptions on the epidemiological situation of leishmaniasis in this country. The objective of this study is to present descriptive data about the epidemiology of leishmaniasis in Nicaragua in the context of the distribution of this neglected tropical disease (NTD) in the Americas. This paper also provides an epidemiological update on different forms of leishmaniasis found in the three administrative regions of Nicaragua and its municipalities. Health authorities from the Ministry of Health of Nicaragua (MINSA) provided the entomological and epidemiological information for the different forms of the disease from 2001 to 2018. Prevalence, incidence rates, clinical classification of disease, age groups, sex, and geographic distribution by municipality and department are described in this study. Approximately 90%–95% of the national patients corresponded to CL and 5–10% correspond to MCL. The disease is distributed in the three regions of the country, with a higher burden in the Departments of Jinotega, Matagalpa and Atlántico Norte. The municipalities with the highest proportion of patients were El Cuá (23.92%), Waslala (14.16), Santa Maria de Pantasma (9.62%), Rancho Grande (9.03%) and Siuna (7.67%). There is an expansion of spatial distribution of CL and MCL in the North Central and South Atlantic regions of the country. These results could inform interventional strategies to address the burden of leishmaniasis in Nicaragua, which would improve the likelihood of meeting the goals for the Leishmaniasis Plan of Action for the Americas.
Collapse
Affiliation(s)
- Santiago E Hernández-Bojorge
- Global and Planetary Heal, College of Public Health, University of South Florida, Tampa, Florida, United States.,Department of Microbiology and Parasitology, Faculty of Medical Sciences, Universidad Nacional Autónoma de Nicaragua-Managua, Nicaragua
| | - Gerardo G Blass-Alfaro
- Department of Microbiology and Parasitology, Faculty of Medical Sciences, Universidad Nacional Autónoma de Nicaragua-Managua, Nicaragua
| | - Marissa A Rickloff
- Department of Epidemiology, College of Public Health, University of South Florida, Tampa, Florida, United States
| | - Manuel J Gómez-Guerrero
- Department of Microbiology and Parasitology, Faculty of Medical Sciences, Universidad Nacional Autónoma de Nicaragua-Managua, Nicaragua
| | - Ricardo Izurieta
- Global and Planetary Heal, College of Public Health, University of South Florida, Tampa, Florida, United States
| |
Collapse
|
4
|
Machado A, Lyon S, Rocha‐Silva F, Assunção C, Hernandez M, Jorge D, Cunha A, Barbosa V, Fernades B, Abreu A, Goulart L, Goulart I, Coelho E, Caligiorne R. Novel PCR primers for improved detection of
Mycobacterium leprae
and diagnosis of leprosy. J Appl Microbiol 2020; 128:1814-1819. [DOI: 10.1111/jam.14592] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2019] [Revised: 01/15/2020] [Accepted: 01/21/2020] [Indexed: 11/29/2022]
Affiliation(s)
- A.S. Machado
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| | - S. Lyon
- Hospital Eduardo de Menezes Belo Horizonte Minas Gerais Brazil
| | - F. Rocha‐Silva
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| | - C.B. Assunção
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| | - M.N. Hernandez
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
- Hospital Eduardo de Menezes Belo Horizonte Minas Gerais Brazil
| | - D.S. Jorge
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
- Hospital Eduardo de Menezes Belo Horizonte Minas Gerais Brazil
| | - A.C.G. Cunha
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
- Hospital Eduardo de Menezes Belo Horizonte Minas Gerais Brazil
| | - V.G. Barbosa
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| | - B. Fernades
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| | - A.G.S. Abreu
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| | - L.R. Goulart
- Laboratório de Nanobiotecnologia Instituto de Genética e Bioquímica Universidade Federal de Uberlândia Uberlândia Minas Gerais Brazil
| | - I. Goulart
- Laboratório de Nanobiotecnologia Instituto de Genética e Bioquímica Universidade Federal de Uberlândia Uberlândia Minas Gerais Brazil
| | - E.A.F. Coelho
- Programa de Pós‐Graduação em Ciências da Saúde: Infectologia e Medicina Tropical Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil
| | - R.B. Caligiorne
- Hospital Santa Casa de Belo Horizonte Ensino e Pesquisa Programa de Pós‐Graduação Belo Horizonte Minas Gerais Brazil
| |
Collapse
|
5
|
Vernal S, Bueno-Filho R, Gomes CM, Roselino AM. Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil. Rev Soc Bras Med Trop 2019; 52:e20180172. [PMID: 30994795 DOI: 10.1590/0037-8682-0172-2018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2018] [Accepted: 12/05/2018] [Indexed: 11/22/2022] Open
Abstract
INTRODUCTION American tegumentary leishmaniasis (ATL) and leprosy share common areas of prevalence, but reports of coinfection are scarce. METHODS We report a series of 9 ATL-leprosy cases and discuss the association. An integrative diagram to analyze the clinico-immunological features of coinfection with both diseases. RESULTS Nine patients with leishmaniasis (5 cutaneous, 3 mucocutaneous, 1 disseminated case) exhibited concurrent infection with distinct clinical forms of leprosy. Our diagram-based analysis evidenced a divergent clinico-immunological spectrum for each disease in 8 out of 9 cases. CONCLUSIONS The spectrum of ATL-leprosy comorbidity suggests that the host has a specific immune response against each pathogen.
Collapse
Affiliation(s)
- Sebastian Vernal
- Divisão de Dermatologia, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
| | - Roberto Bueno-Filho
- Divisão de Dermatologia, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
| | - Ciro Martins Gomes
- Departamento de Dermatologia, Universidade de Brasília, Brasília, DF, Brasil
| | - Ana Maria Roselino
- Divisão de Dermatologia, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil
| |
Collapse
|